SCHEMBL6154531

SCHEMBL6154531

CC(C)(C)OC(=O)N1CCC(Nc2ccc(C(N)=O)cc2F)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 6/20 0.54
ALDH1A1 P00352 2/20 0.52
NPC1 O15118 1/20 0.51
MAPT P10636 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CHEK2 O96017 1/20 0.48
PARP14 Q460N5 1/20 0.47
HDAC1 Q13547 1/20 0.46
DPP4 P27487 1/20 0.45
KMT2A Q03164 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
CNR1 P21554 1/20 0.44
ADORA2A P29274 1/20 0.44
EPHX1 P07099 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3512756 0.88 ALDH1A1 (0.55) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL6154547 0.87 GPR119 (0.52) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL6154057 0.87 GPR119 (0.54) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL6154090 0.87 GPR119 (0.54) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL15565385 0.86 ALDH1A1 (0.56) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL25390329 0.84 USP30 (0.59) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL6154671 0.83 ALDH1A1 (0.50) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL6154407 0.82 ALDH1A1 (0.72) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL377372 0.82 ALDH1A1 (0.58) GPR119ALDH1A1NPC1MAPTMAPK1
SCHEMBL354114 0.82 L3MBTL1 (0.58) GPR119ALDH1A1NPC1MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050182040-A1 Benzamide derivatives DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-18 US disclosed
EP-1500643-A1 BENZAMIDE DERIVATIVES SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182040-A1 Benzamide derivatives ROCK1, ROCK2, NHERF1 GPR119 279/4885ALDH1A1 2454/4885NPC1 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.